INOTEK PHARMACEUTICALS CORP's ticker is and the CUSIP is 45780VAB8. A total of 11 filers reported holding INOTEK PHARMACEUTICALS CORP in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TFG Asset Management GP Ltd | 7,700,000 | $6,036,000 | 0.92% |
| Telemetry Investments, L.L.C. | 1,750,000 | $1,403,000 | 0.54% |
| Springhouse Capital Management, LP | 1,300,000 | $988,000 | 0.48% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 8,750,000 | $7,016,000 | 0.45% |
| Bruce & Co., Inc. | 2,000,000 | $1,600,000 | 0.35% |
| DAFNA Capital Management LLC | 600,000 | $452,000 | 0.24% |
| Orbimed Advisors | 7,000,000 | $5,918,000 | 0.08% |
| Baker Brothers Advisors | 5,000,000 | $4,009,000 | 0.04% |
| Citadel Advisors | 7,500,000 | $5,700,000 | 0.00% |